Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levodopa (Siliba) for young children with myopia and amblyopia
ChiCTR2200064571Phase 4Not yet recruiting
- Sponsor
- Hunan Children's Hospital
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of levodopa in myopia and amblyopia, sponsored by Hunan Children's Hospital. Primary endpoints: Uncorrected visual acuity, Corrected visual acuity and 5 more. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
levodopa
03
Conditions
myopiaamblyopia
Beyond the preview
Go deeper on ChiCTR2200064571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064571.